Biotechnology News

April 24, 2014

FLAGSTAFF, Ariz. & LONDON--(BUSINESS WIRE)--W. L. Gore & Associates joined with leaders across the vascular and endovascular community in honoring four European physicians as Pioneers in Performance.

April 24, 2014

BASEL, Switzerland--(BUSINESS WIRE)--CRISPR Therapeutics, a biopharmaceutical company focused on the breakthrough gene-editing technology CRISPR-Cas9, has raised $25 million in a series A investment from Versant Ventures.

April 24, 2014

PARIS--(BUSINESS WIRE)--Fresenius Kabi, a global health care company that specializes in life-saving medicines and technologies for infusion, transfusion and clinical nutrition, today introduced its new Lovo cell-processing system at the 2014...

April 24, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (Nasdaq: SRPT), a developer of innovative RNA-based therapeutics, today announced that it has priced an underwritten public offering of an aggregate of 2,650,000 shares.

April 23, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) will report its first quarter 2014 financial results on May 5, 2014, after close of market.

April 23, 2014

TUCSON, Ariz.--(BUSINESS WIRE)--U.S. court dismisses TSI lawsuit against Azbil BioVigilant

April 23, 2014

TRENTON, N.J.--(BUSINESS WIRE)--With the theme The Culture Connection: Transforming and Creating Cultures that Thrive! BioNJ, will host its 3rd Annual Human Resource Industry Conference on May 9.

April 23, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer will present at the Robert W. Baird 2014 Growth Stock Conference on Wednesday, May 7 at 4:45pm CT at the Four Seasons Hotel in Chicago.

April 23, 2014

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) will host a conference call at 8:30 a.m. EDT (1:30 p.m. BST) on Wednesday, April 30, 2014, to discuss the company’s financial results for the first quarter of 2014. Management will review the...

April 23, 2014

WASHINGTON--(BUSINESS WIRE)--2014 BIO International Convention Super Sessions to address advancements in oncology, the state of the industry and the Accelerating Medicines Partnership.

April 23, 2014

MINNEAPOLIS--(BUSINESS WIRE)--Starkey Hearing Technologies, one of the world’s leading hearing technology companies, is excited to introduce Halo™, a Made for iPhone® hearing aid engineered to be compatible with iPhone, iPad® and iPod touch®. ...

April 23, 2014

BETHESDA, Md.--(BUSINESS WIRE)--A joint effort by HJF and USU to license a promising breast cancer vaccine to reduce recurrence rates has received the 2014 has received an award from the Federal Laboratory Consortium.

April 23, 2014

GAITHERSBURG, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (NASDAQ: GLYC) announced today that it has expanded its management team with the addition of Armand Girard as Vice President, Corporate Development. Mr. Girard has extensive partnering...

April 23, 2014

AURORA, Colo.--(BUSINESS WIRE)--BaroFold has received a patent providing additional protections over PreEMT technology. PreEMT is used to improve the tolerability, efficacy and safety of a wide variety of protein therapeutics.

April 23, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) today announced that the U.S. Food and Drug Administration (FDA) has approved a new reconstitution system for ADVATE (Antihemophilic Factor [Recombinant]). ADVATE and the...

April 23, 2014

CINCINNATI--(BUSINESS WIRE)--Aerpio Therapeutics closed a $22M financing round led by new investor OrbiMed, with existing investors participating for support expanded development of AKB-9778 in DME and AKB-4924 in IBD.

April 23, 2014

SAN FRANCISCO--(BUSINESS WIRE)--Lieff Cabraser reminds CytRx stock holders of the May 14, 2014 deadline to move for appointment as lead plaintiff in a securities class action.

April 23, 2014

BEVERLY, Mass.--(BUSINESS WIRE)--AdvaStim, Inc., www.advastim.com announced today that it has entered the research and development market with a new hardware/software solution for...

April 23, 2014

SALT LAKE CITY--(BUSINESS WIRE)--Tolero Pharmaceuticals, Inc., a clinical-stage company developing treatments for serious hematological diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation...

April 23, 2014

PORTOLA VALLEY, Calif.--(BUSINESS WIRE)--Steve Gex, an accomplished leader of several medical-device companies in women's healthcare, has been named chief executive officer of Focal Therapeutics, the company said today. Gex has previously been...

April 23, 2014

CORAL GABLES, Fla.--(BUSINESS WIRE)--Catalyst Pharmaceutical announced today it has begun the process required to establish an expanded access program (EAP) to make available in the United States for Firdapse.

April 23, 2014

BELGRADE, Mont.--(BUSINESS WIRE)--Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft materials and bioactive coatings for medical applications, announced today that positive results...

April 23, 2014

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that its Captisol-enabled™ (propylene glycol-free) Melphalan (CE Melphalan) development and commercial partner Spectrum Pharmaceuticals (NASDAQ: SPPI) has...

April 23, 2014

DALLAS/FORT WORTH, Texas--(BUSINESS WIRE)--Neos Therapeutics, Inc. (“Neos” or “the Company”), a highly differentiated oral drug delivery company with an exciting portfolio of proprietary technologies and a late-stage pipeline of innovative...

April 23, 2014

WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences Announces Collaboration with Connecticut Children’s Medical Center (CCMC) for Genetic Analysis of Autism Spectrum Disorder (ASD) Patients

April 23, 2014

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that company executives are scheduled to participate in the following upcoming investor conferences: Deutsche Bank 39th Annual Health Care Conference in...

April 23, 2014

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a clinical-stage biopharmaceutical company developing topical non-antibiotic antimicrobial products, today announced that it is introducing a new eye care...

April 23, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions will release 1Q 2014 financial results and conduct a conference call at May 8, 2014.

April 23, 2014

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceutical’s Pivotal Trial of Captisol-Enabled™ (Propylene Glycol-Free) Melphalan Meets Primary Endpoint

April 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB) today reported first quarter 2014 results, including revenue of $2.1 billion, a 51% increase compared to the first quarter of 2013. The revenue growth year-over-year was driven by...

April 23, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals Announces $22.5 Million Series B Financing

April 23, 2014

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals announced that the European Commission has granted an orphan drug designation to Soliris® for the prevention of graft rejection following solid organ transplantation.

April 23, 2014

SAN DIEGO--(BUSINESS WIRE)--OncoSec Medical Names Adil Daud, M.D. as Chief Clinical Strategist

April 23, 2014

SAN RAMON, Calif.--(BUSINESS WIRE)--rfXcel, a cloud leader in Product Serialization, Traceability, DQSA, China and Global Compliance selected by SciClone Pharmaceuticals for meeting its China Compliance and Anti-Counterfeiting Goal.

April 23, 2014

BALTIMORE--(BUSINESS WIRE)--Dr. Robert Gallo Reflects on 30 Years Since Announcing HIV as the Cause of AIDS: HIV Co-discoverer hopeful for HIV cure and vaccine, focuses on global preparedness for new viral threats

April 23, 2014

IRVINE, Calif.--(BUSINESS WIRE)--ResearchDx, LLC of Irvine, California announced today that it has received a 2013 Strategic Partner Award from WuXi AppTec, Ltd.

April 23, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 29, 2014. The company’s results include the addition of Life...

April 23, 2014

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--23andMe, the leading personal genetics company, is celebrating National DNA Day by taking an in-depth look at what Americans know about their DNA and how genetics play a role in our everyday lives.

April 23, 2014

MENLO PARK, Calif.--(BUSINESS WIRE)--Personalis, Inc., a leading provider of genome-based diagnostics, announced today that its onsite clinical laboratory has received accreditation from the College of American Pathologists (CAP), meeting the...

April 23, 2014

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Fenofibrate Capsules, USP 43 mg and 130 mg a therapeutic equivalent generic version of ANTARA® (fenofibrate) capsules, in the US market...

April 23, 2014

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife AB (STO:VITR): · Sales growth was 12 percent in local currency. Sales amounted to SEK 119 (105) million, corresponding to an increase of 14 percent in SEK. · Operating income (EBIT)...

April 23, 2014

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: The Nomination Committee of Precise Biometrics AB (STO:PREC) has provided the Company with the below recommendation regarding election of members of the Board, Chairman of the Board and remuneration of...

April 23, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company announces Canadian approval for the company’s KXL II System.

April 22, 2014

NEW YORK & SEOUL, South Korea--(BUSINESS WIRE)--Bristol-Myers Squibb and Samsung BioLogics Expand Manufacturing Agreement

April 22, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc., a developer of innovative RNA-based therapeutics, today announced that it is offering to sell, subject to market and other conditions, up to $100 million of its stock.

April 22, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on April 22, 2014.